Development Of An Indirect Elisa Using The Recombinant Nucleocapsid Protein As Antigen For Detection Of Antibodies To Newcastle Disease Virus by Md Saad, Norsharina
  
 
UNIVERSITI PUTRA MALAYSIA 
 
 
 
 
DEVELOPMENT OF AN INDIRECT ELISA USING THE RECOMBINANT 
NUCLEOCAPSID PROTEIN AS ANTIGEN FOR DETECTION OF 
ANTIBODIES TO NEWCASTLE DISEASE VIRUS 
 
 
 
 
 
 
NORSHARINA BT MD SAAD 
 
 
 
 
 
 
 
FBSB 2007 14 
DEVELOPMENT OF AN INDIRECT ELISA USING THE RECOMBINANT 
NUCLEOCAPSID  PROTEIN AS ANTIGEN FOR DETECTION OF ANTIBODIES 
TO NEWCASTLE DISEASE VIRUS
NORSHARINA BT MD SAAD
MASTER OF SCIENCE
UNIVERSITI PUTRA MALAYSIA
2007
PDF processed with CutePDF evaluation edition www.CutePDF.com
DEVELOPMENT OF AN INDIRECT ELISA USING THE RECOMBINANT 
NUCLEOCAPSID  PROTEIN AS ANTIGEN FOR DETECTION OF ANTIBODIES 
TO NEWCASTLE DISEASE VIRUS
By
NORSHARINA BT MD SAAD
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, in
Fulfilment of the Requirements for the Degree of Master of Science
March 2007
ii
To my dearest father and mother 
for their infinite love, care and support.
 I owe them everything I have today
To my beloved husband and son
Also my relatives and friends
iii
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of the 
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Development of an Indirect Elisa Using the Recombinant Nucleocapsid  Protein as 
Antigen for Detection of Antibodies to Newcastle Disease Virus
By
NORSHARINA BINTI MD SAAD
March 2007
Chairman : Professor Datin Paduka Khatijah Mohd. Yusoff, PhD
Faculty : Biotechnology and Biomolecular Sciences
Newcastle disease (ND) is a virulent form of poultry disease that has the potential to cause 
100% mobidity and mortality.  The continuing threat of ND to the poultry industry requires 
routine testing of vaccinated chickens to determine that they have been adequately 
immunised by vaccination. Enzyme-linked immunosorbent assays (ELISA) which use 
commercially available reagents are presented as alternatives to the procedure for detection 
of Newcastle disease virus (NDV) antibodies. The nucleocapsid protein has been shown to 
immunogenic in nature, and play key roles in diagnostic ELISA for detection of antibody.
A purified recombinant nucleocapsid protein (NP) of NDV highly expressed in Escherichia 
coli (E. coli) was used as the coating antigen in an indirect ELISA to detect the presence of 
NDV antibodies in a cohort of chicken sera. The test was standardised using sera from 
vaccination study and obtained from Charles River SPAFAS Laboratories, USA. The NP-
ELISA was standardised at an antigen concentration of 1.5 μg/ml, test serum dilution of 
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1:200 and conjugate dilution of 1:2000. The cut-off value of the NP-ELISA of 0.238 was 
determined by a receiver operating characteristic (ROC) analysis. An assay of 315 chicken 
serum samples against NDV antibodies showed that the NP-ELISA had 92.06% sensitivity 
and 93.2% specificity compared to NDV hemagglutination–inhibition (HI) test. This was in 
good agreement between the two serological methods (κ =0.848). In the serum 
neutralization test (SNT), the result shows that there was no correlation observed between 
HI and SNT. It was observed that the field serum samples found positive or with high titer 
in the HI test were negative or have low titer for SNT. This suggests that different epitopes 
on the antigen have been recognized by each of the tests. The result shows that the 
recombinant NP antigen is recognized by antibodies specific to the other poultry pathogens 
and the cross reactivity is high for Paramyxovirus-2 (PMV-2) and Paramyxovirus-3 (PMV-
3) but low reaction by other poultry pathogen [avian influenza (AI), avian 
encephalomyelitis (AE), infectious laryngotracheitis (ILT), infectious bronchitis (IB), and 
infectious bursal disease (IBD)]. The titre of ND antibodies can be determined using NP-
ELISA formula, Log10Titre = 1.0* Log(S/P) + 3.45. This formula was derived after getting 
the linearity graph between NP-ELISA to commercial ND test kit. This finding indicates the
potential application of the E. coli produced NP protein as antigen in indirect ELISA for the 
detection of NDV antibody. The NP-ELISA was successfully developed and very useful 
which is more or as efficient as commercial kits, thus the cost of NP-ELISA is cheaper than 
commercial kits. 
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Penyakit Newcastle adalah penyakit virus ternakan yang berpotensi menyebabkan 100% 
morbiditi dan kematian. Ancaman penyakit Newcastle yang berterusan berlaku dalam 
industri ternakan memerlukan ujian rutin bagi ayam yang telah divaksinkan, untuk 
menentukan ayam-ayam tersebut telah diimunisasi dengan mencukupi melalui vaksinasi. 
Produk ELISA yang telah dikomersilkan sekarang adalah sebagai kaedah alternatif dalam 
pengesanan antibodi virus penyakit Newcastle. Protein nucleocapsid telah menunjukkan 
immunogenik dalam keadaan semulajadi, dan berperanan dalam ujian diagnostik ELISA 
untuk mengesan antibody.
Protein rekombinan nuleocapsid daripada virus Newcastle ayam telah ditulenkan dan 
diekspreskan dengan banyaknya dalam sistem E.coli telah digunakan sebagai antigen dalam 
ujian ELISA untuk mengesan kehadiran antibodi virus Newcastle di dalam serum ayam. 
Ujian ini yang telah dipiawaikan menggunakan serum daripada kajian pemvaksinan dan 
diperolehi daripada makmal Charles River SPAFA, USA. Keadaan ujian NP-ELISA telah 
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dipiawaikan pada kepekatan antigen 1.5μg/mL, pencairan serum yang diuji pada 1:200 dan 
pencairan konjugat pada 1:2000. Nilai takat penentu NP-ELISA ialah 0.238 yang telah
ditentukan melalui analisis ciri-ciri memproses penerimaan (ROC). Dalam menguji 315 
sampel serum ayam terhadap antibodi virus Newcastle telah menunjukkan NP-ELISA
mempunyai sensitiviti 92.06% dan spesifisiti 93.2% yang dibandingkan dengan ujian 
penghalang hemagglutinin (HI). Dalam dua ujian serologi ini menunjukkan persetujuan 
yang baik dengan nilai κ = 0.848. Dalam ujian peneutralan serum, keputusan menunjukkan 
tiada hubungan antara HI dan ujian peneutralan tersebut. Ini telah diuji apabila sampel 
serum lapangan menunjukkan bacaan titer yang tinggi dengan ujian HI tetapi sebaliknya 
bagi ujian peneutralan serum. Setiap ujian akan mengenali antibodi yang berbeza 
berdasarkan epitop pada antigen dalam ujian yang digunakan. Keputusan ujian 
menunjukkan antigen rekombinan NP dapat dikenali oleh antibodi patogen ternakan yang 
lain dan tindak balas bercanggah yang tinggi berlaku pada PMV-2 dan PMV-3, tetapi tindak 
balas bercanggah yang rendah pada patogen ternakan yang lain [avian influenza (AI), avian 
encephalomyelitis (AE), infectious laryngotracheitis (ILT), infectious bronchitis (IB), and 
infectious bursal disease (IBD)]. Titer antibodi bagi penyakit Newcastle boleh ditentukan 
dengan menggunakan formula NP-ELISA, Log10Titer=1.0*Log (S/P)+3.45. Formula ini 
ditentukan apabila mendapatkan graf yang linear antara NP-ELISA dengan produk ELISA 
komersial.. Penemuan ini menunjukkan potensi kegunaan protein NP yang dihasilkan dalam 
E.coli sebagai antigen dalam ‘indirect’ ELISA untuk mengesan antibodi virus Newcastle. 
NP-ELISA telah berjaya dihasilkan dan sangat berguna di mana ianya adalah sama atau 
lebih efisen dengan produk komersial. Tambahan pula kos NP-ELISA adalah murah 
daripada produk  komersial.       
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1CHAPTER 1
Introduction
Newcastle disease (ND) is a widespread and an economically important poultry disease 
which affects chickens, turkeys and others birds.  As a result, our poultry industries 
suffer huge losses with high mortality, poor food utilization and reduced egg 
production.  It is caused by the Newcastle disease virus (NDV). The virus not only 
attacks poultry and birds, but it also infects man and other mammals. Unlike in the 
other animals, ND has been recognized in man almost entirely as localized eye 
infection (Brandly and Hanson, 1965), headache, and flu-like symptoms rarely 
becoming severe or leading to visual impairment. 
The virus is relatively stable in nature, remaining infective for weeks at room 
temperature (22°C) and surviving for several hours in a wide range of pH (3-10). It can 
survive for 20 days in the forest litter but the survival can be prolonged to 255 days in 
water, soil, carcasses, eggs and feathers (Hanson, 1980). The survival rate can be 
prolonged even further in meat and bones up to 6 months at 1°C.  On the other hand, 
the virus can be inactivated by pasteurization of eggs and egg products at 64°C for 4.5 
minutes, processing meat for 30 minutes at 30°C or 1 minute at 80°C. Transmission is 
by contact with infected products or by aerosol from infected live birds. Mechanical 
transmission between premises can occur from contaminated footwear, clothing, skin, 
feed, trucks, and poultry or egg handling equipment.   
2NDV in its many different forms and pathotypes occurs as regular, frequent epizootics 
throughout Asia, Africa, and South America, and sporadic epizootics occur in Europe 
(Williams et al., 1997) (Figure 1; OIE 2002). The virus is enzootic in some areas of the 
world including Malaysia where sporadic outbreaks occur. As reported by the 
Veterinary Research Institute, Ipoh, 38 new cases were isolated from chickens in 2003. 
However, in 2004 the NDV cases increased to 122 cases; majority of these were 
isolated from chickens with four cases from ducks. The number of cases increased to 
130 (from chicken) and 16 (from duck) in 2005. However, in 2006, the cases of NDV 
were reduced to 107 and 5 cases isolated from chicken and duck respectively.  Most of 
the domestic outbreaks occurred in areas with high density of poultry farms, with 
reduced number of outbreaks among small holders and in the village.
 To date, vaccination by coarse spray is seldom practised in Malaysia. The instructions 
given in the vaccine manufacturer’s pamphlet for the particular vaccine should be 
studied by the farmers carefully in terms of storage, handling, dilution and vaccination 
routes. Efforts to raise the awareness of farmers and the general public of the disease 
and current control measures have been very effective judging by the response to the 
call for vaccination. 
In addition, efforts to control and prevent ND through efficient vaccination programs 
and corresponding serological monitoring are also constantly being carried out (Ricardo 
et al., 2000). The continuing threat of ND to the poultry industry requires routine 
testing of vaccinated chickens to determine that they have been adequately immunized 
by vaccination. Diagnosis of ND has progressed from the conventional virus isolation 
and serological tests to the use of monoclonal antibodies and semi-automated enzyme 
3linked immunoassay (ELISA).  These are further improved by the application of 
molecular-based techniques, such as reverse transcription polymerase chain reaction 
(RT-PCR), oligonucleotide probes, genomic fingerprint and nucleotide sequencing
(reviewed in Aldous and Alexander, 2001; Yusoff and Tan, 2001). The choice of the 
diagnostic methods is mainly based on the consideration of cost, speed, specificity and 
sample size.
The haemagglutination-inhibition (HI) test is the most widely used conventional 
serological method for detection of NDV antibodies as it is quite specific and gives 
reproducible results (Ricardo et al., 2000).  In recent years, various indirect ELISAs 
have been developed and evaluated (Snyder et al., 1983; Thayer et al., 1987; Adair et 
al., 1989; de Witt et al., 1992), and these have been correlated to the HI test (Brown et 
al., 1990). The potential applications of the recombinant NP protein as alternative 
antigen in indirect ELISA to detect the presence of ND antibodies, and in diagnosis of 
ND were explored in this study as they could contribute to the screening and 
monitoring of the disease.
4Figure 1: Animal Health Status Worldwide in 2002  (Source: OIE, Animal Health 
Status Worldwide in 2002).  Note that due to rigorous vaccination programmes 
ND is no longer endemic in many countries (OIE., Animal Health Status 
Worldwide in 2005)
Disease reported present
Disease reported absent
Data unavailable or incomplete
5Significance of the study
The objective of this study was to produce the recombinant NP protein in bulk as 
antigen for indirect ELISA to detect the presence of anti-NDV antibodies. It is also 
aimed to study the sensitivity and specificity of the NP-ELISA using true positive and 
negative sera. Furthermore, the NP-ELISA was also compared with the HI test, serum 
neutralization test (SNT) and other ELISA tests.  It is also important to ensure 
production of such an NP-ELISA test kit is as efficient as the other commercially 
available kits such as Idexx and BioChek are usually very expensive, whereas a locally 
produced NP-ELISA test kit can reduce the cost of ND testing for screening in 
surveillance and monitoring programmes. 
